glp-1 vs insulin Favorable Effects of Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine Targeting GLP-1, GIP & GCG

We outline the potential for multitarget therapy incorporating reninangiotensinaldosterone system inhibitors, sodiumglucose co-transporter-2 inhibitors, incretin-based treatments and nsMRAs to improve cardiovascular and kidney outcomes in patients with overweight/obesity and T2DM

Nat Rev Endocrinol (2017) 13(10):61022

Research suggests high intravenous doses can improve liver function in patients with fatty liver disease

doi:10.1007/s00404-024-07849-9 Ivanisevic M, Herman M, Horvaticek M, Vucic Lovrencic M, Delmis J

Hair Growth & Follicular Health Recent investigations indicate that GHK-Cu: Activates dermal papilla cells, the specialized cells at the base of hair follicles controlling growth phase (anagen) entry Reduces follicle sensitivity to DHT (dihydrotestosterone), the hormone primarily responsible for androgenetic alopecia Promotes angiogenesis to the scalp, increasing oxygen and nutrient delivery to follicles Suppresses inflammatory cytokines that contribute to follicle miniaturization Enhances hair density and thickness through collagen synthesis and follicular cell proliferation Safety Considerations The safety profile is well documented